Skip to main content

Ineos chairman blasts European regulation

18th February 2019

Submitted by:

Andrew Warmington

Sir Jim Ratcliffe, founder, chairman and 60% owner of Ineos, has written an open letter to European Commission President Jean-Claude Juncker, lambasting European chemical regulation in general and ‘green taxes’ in particular. These, he said, has been steadily driving investment away from Europe over many years.

This came a month after Ineos, the world’s largest privately owned chemicals company, announced that it would invest €3 billion to build a new ethane gas cracker and world-scale propane dehydrogenation unit at Antwerp, which is the first of its kind in Europe for 20 years. The company already has nine operations there.

A “well known CEO of a European chemicals company” had asked him “Are you quite mad?” shortly afterwards, Ratcliffe said. His answer to that was that Ineos could afford to invest in Europe because it can bring in cheap feedstocks and consumes them internally. No others are likely to follow suit.

“Nobody but nobody in my business seriously invests in Europe. They haven’t for a generation. Everyone in my business does, however, invest in the USA, Middle East or China, or indeed, all three. The USA is in the middle of a $200 billion spending spree on 333 new chemical plants. China has spent that sum annually for many years, constructing its own chemical building blocks.”

Europe, he continued, was formerly the world leader in chemicals, but its market share has halved from 30% to 15% in the past decade. “Europe is no longer competitive. It has the worlds most expensive energy and labour laws that are uninviting for employers. Worst of all, it has green taxes that, at best, can be described as foolish as they are having the opposite effect to how they were intended.”

As a result, he said, investment is going instead to the US and China and taking downstream manufacture with it. The US is now rebuilding its chemicals industry and replacing old units with new ones that have far lower emissions; it does not impose ‘green taxes’ but instead insists on “the very highest environmental standards before it issues permits for new builds”.

Europe, he concluded, retains an industry built generations ago with old environmental standards and has scared investment away, while America has welcomed new investment, created new jobs and improved environmental standards. “I know who looks smarter … Europe, reminds me somewhat of the Charge of the Light Brigade, immortalised in Tennyson’s wonderful poem, full of valour and good intention but the outcome will not be pretty.”

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production

Submitted by:

Andrew Warmington

Nippon Shokubai's API Facility in Japan

Nucleic acid API boost

Nippon Shokubai is to expand its GMP capacity for nucleic APIs tenfold It will install

Submitted by:

Andrew Warmington

Flamma's facility in Dalian

Flamma opens in China

Italian CDMO Flamma Group has officially opened its new cGMP plant at Dalian, China, where

Submitted by:

Andrew Warmington

GL Chemtec has opened a new kilo lab

GL Chemtec completes kilo lab

CDMO GL Chemtec has announced the completion of a cGMP kilo lab at Oakville, Ontario

Submitted by:

Andrew Warmington

Sterling's facility at Deeside, UK

CDMOs in ADC investments

Five CDMOs across the world have separately announced investments in antibody-drug conjugates (ADCs). Piramal Pharma is

Submitted by:

Andrew Warmington

Afyren Neoxy plant

Milestones for two greentech firms

Afyren has achieved continuous production at its Afyren Neoxy plant at Clermont-Ferrand (pictured)

Submitted by:

Andrew Warmington

Origin by Ocean derives its materials from sargassum

CABB in algae biorefinery deal

CABB has agreed a strategic partnership to establish a first-in-kind algae biorefinery at its site at Kokkola

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants

Submitted by:

Andrew Warmington

Aether to supply Seqens

Indian firm Aether Industries has entered into a manufacturing agreement with Chemoxy International, a UK-based

Submitted by:

Andrew Warmington

New model for biocatalysts

BASF, the Austrian Research Centre of Industrial Biotechnology (ACIB) and the University of Graz in

Submitted by:

Andrew Warmington

CBE JU funds 31 more projects

The Circular Bio-based Europe Joint Undertaking (CBE JU), a €2 billion partnership between the EU

Submitted by:

Andrew Warmington

Ribbon cutting ceremony at Lubrizol's new office

Lubrizol opens London office

Lubrizol has opened a new office in Hammersmith, London. This will be home to a

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site

Submitted by:

Andrew Warmington

CCT collaboration for Givaudan

Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable

Submitted by:

Andrew Warmington

REACH Authorisation

Candidate List ‘reaches’ 250

The European Chemicals Agency (ECHA) has added three more substances to the Candidate List of

Submitted by:

Andrew Warmington

Staff at Brenntag's newly acquired Czech site

CO2-free distribution site first

Brenntag has officially inaugurated what it claims to be the first CO2-emission-free chemical distribution site

Submitted by:

Andrew Warmington